Genotyping the risk of anthracycline-induced cardiotoxicity
- 19 April 2007
- journal article
- review article
- Published by Springer Nature in Cardiovascular Toxicology
- Vol. 7 (2) , 129-134
Abstract
Anthracyclines belong to the most successful antineoplastic drugs, but they are cardiotoxic, which may result in congestive heart failure (CHF). The CHF risk increases with the cumulative anthracycline dose, but it seems also to be modified by individual factors. A role of the individual genetic background is consistent with the altered sensitivity to anthracyclines observed in many transgenic and knockout mouse strains. First clinical data obtained in humans suggest the existence of predisposing variants in genes involved in the oxidative stress, and in the metabolism and transport of anthracyclines. These data will have to be verified in further clinical trials before any attempts of their application in the individual cardiotoxicity prediction can be undertaken. In the meantime, anthracycline-induced cardiotoxicity can be best reduced by application of liposomal anthracycline formulations or by a co-medication with the cardioprotective iron chelator dexrazoxane.Keywords
This publication has 41 references indexed in Scilit:
- Clinical heart failure in a cohort of children treated with anthracyclines: A long-term follow-up studyEuropean Journal of Cancer, 2006
- Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemiaBlood, 2006
- A Common Genetic Variant Is Associated with Adult and Childhood ObesityScience, 2006
- Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directionsOncogene, 2006
- Prospective longitudinal evaluation of doxorubicin‐induced cardiomyopathy in sarcoma patients: A report of the late effects surveillance system (LESS)Pediatric Blood & Cancer, 2005
- Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategiesBritish Journal of Haematology, 2005
- Cardiac DT‐diaphorase contributes to the detoxification system against doxorubicin‐induced positive inotropic effects in guinea‐pig isolated atriaClinical and Experimental Pharmacology and Physiology, 2004
- Glutathione S-transferase overexpression protects against anthracycline-induced H9C2 cell deathAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Shiga-Like Toxin II Impairs Hepatobiliary Transport of Doxorubicin in Rats by Down-Regulation of Hepatic P Glycoprotein and Multidrug Resistance-Associated Protein Mrp2Antimicrobial Agents and Chemotherapy, 2003
- Cardiac Resistance to Adriamycin in Transgenic Mice Expressing a Rat alpha-Cardiac Myosin Heavy Chain/Human Multiple Drug Resistance 1 Fusion GeneHuman Gene Therapy, 1999